Global Crude Heparin Market Insights and Forecast to 2027

Publisher Name :
Date: 07-Jun-2021
No. of pages: 112
Inquire Before Buying

Crude Heparin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crude Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Pig Intestine Mucosa Heparin

- Bovine Heparin and Others

- Pig intestine mucosa heparin is almost the only used and efficient type, taking 99.47% market share in 2019, in terms of volume.

Segment by Application

- Unfractionated Heparin (UFH)

- Low-Molecular-Weight Heparin (LMWH)

- LMWH is the largest consumer group, with market share of 89.03% in 2019, in terms of volume.

By Company

- Bioiberica

- Shenzhen Hepalink

- Sanofi

- Nanjing King-friend

- Fengrun Biological Technology

- Aspen Oss

- Hebei Changshan Biochemical

- Changzhou Qianhong

- Hepac (Darling Ingredients)

- Huaian MDC Pharmaceutical

- Yantai Dongcheng Biochemicals

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Crude Heparin Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Crude Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type
1.4.2 Pig Intestine Mucosa Heparin
1.4.3 Bovine Heparin and Others
1.3 Market by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application
1.3.2 Unfractionated Heparin (UFH)
1.3.3 Low-Molecular-Weight Heparin (LMWH)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Crude Heparin Sales Estimates and Forecasts 2016-2027
2.2 Global Crude Heparin Revenue Estimates and Forecasts 2016-2027
2.3 Global Crude Heparin Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Crude Heparin Regions by Sales
2.4.1 Global Top Crude Heparin Regions by Sales (2016-2021)
2.4.2 Global Top Crude Heparin Regions by Sales (2022-2027)
2.5 Global Top Crude Heparin Regions by Revenue
2.5.1 Global Top Crude Heparin Regions by Revenue (2016-2021)
2.5.2 Global Top Crude Heparin Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Crude Heparin Sales by Manufacturers
3.1.1 Global Top Crude Heparin Manufacturers by Sales (2016-2021)
3.1.2 Global Top Crude Heparin Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Crude Heparin Sales in 2020
3.2 Global Crude Heparin Revenue by Manufacturers
3.2.1 Global Top Crude Heparin Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Crude Heparin Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Crude Heparin Revenue in 2020
3.3 Global Crude Heparin Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Crude Heparin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Crude Heparin Sales by Type
4.1.1 Global Crude Heparin Historical Sales by Type (2016-2021)
4.1.2 Global Crude Heparin Forecasted Sales by Type (2022-2027)
4.1.3 Global Crude Heparin Sales Market Share by Type (2016-2027)
4.2 Global Crude Heparin Revenue by Type
4.2.1 Global Crude Heparin Historical Revenue by Type (2016-2021)
4.2.2 Global Crude Heparin Forecasted Revenue by Type (2022-2027)
4.2.3 Global Crude Heparin Revenue Market Share by Type (2016-2027)
4.3 Global Crude Heparin Price by Type
4.3.1 Global Crude Heparin Price by Type (2016-2021)
4.3.2 Global Crude Heparin Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Crude Heparin Sales by Application
5.1.1 Global Crude Heparin Historical Sales by Application (2016-2021)
5.1.2 Global Crude Heparin Forecasted Sales by Application (2022-2027)
5.1.3 Global Crude Heparin Sales Market Share by Application (2016-2027)
5.2 Global Crude Heparin Revenue by Application
5.2.1 Global Crude Heparin Historical Revenue by Application (2016-2021)
5.2.2 Global Crude Heparin Forecasted Revenue by Application (2022-2027)
5.2.3 Global Crude Heparin Revenue Market Share by Application (2016-2027)
5.3 Global Crude Heparin Price by Application
5.3.1 Global Crude Heparin Price by Application (2016-2021)
5.3.2 Global Crude Heparin Price Forecast by Application (2022-2027)
6 North America
6.1 North America Crude Heparin Market Size by Type
6.1.1 North America Crude Heparin Sales by Type (2016-2027)
6.1.2 North America Crude Heparin Revenue by Type (2016-2027)
6.2 North America Crude Heparin Market Size by Application
6.2.1 North America Crude Heparin Sales by Application (2016-2027)
6.2.2 North America Crude Heparin Revenue by Application (2016-2027)
6.3 North America Crude Heparin Market Size by Country
6.3.1 North America Crude Heparin Sales by Country (2016-2027)
6.3.2 North America Crude Heparin Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Crude Heparin Market Size by Type
7.1.1 Europe Crude Heparin Sales by Type (2017-2027)
7.1.2 Europe Crude Heparin Revenue by Type (2017-2027)
7.2 Europe Crude Heparin Market Size by Application
7.2.1 Europe Crude Heparin Sales by Application (2017-2027)
7.2.2 Europe Crude Heparin Revenue by Application (2017-2027)
7.3 Europe Crude Heparin Market Size by Country
7.3.1 Europe Crude Heparin Sales by Country (2017-2027)
7.3.2 Europe Crude Heparin Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Crude Heparin Market Size by Type
8.1.1 Asia Pacific Crude Heparin Sales by Type (2018-2027)
8.1.2 Asia Pacific Crude Heparin Revenue by Type (2018-2027)
8.2 Asia Pacific Crude Heparin Market Size by Application
8.2.1 Asia Pacific Crude Heparin Sales by Application (2018-2027)
8.2.2 Asia Pacific Crude Heparin Revenue by Application (2018-2027)
8.3 Asia Pacific Crude Heparin Market Size by Region
8.3.1 Asia Pacific Crude Heparin Sales by Region (2018-2027)
8.3.2 Asia Pacific Crude Heparin Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Crude Heparin Market Size by Type
9.1.1 Latin America Crude Heparin Sales by Type (2019-2027)
9.1.2 Latin America Crude Heparin Revenue by Type (2019-2027)
9.2 Latin America Crude Heparin Market Size by Application
9.2.1 Latin America Crude Heparin Sales by Application (2019-2027)
9.2.2 Latin America Crude Heparin Revenue by Application (2019-2027)
9.3 Latin America Crude Heparin Market Size by Country
9.3.1 Latin America Crude Heparin Sales by Country (2019-2027)
9.3.2 Latin America Crude Heparin Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Crude Heparin Market Size by Type
6.1.1 Middle East and Africa Crude Heparin Sales by Type (2016-2027)
6.1.2 Middle East and Africa Crude Heparin Revenue by Type (2016-2027)
6.2 Middle East and Africa Crude Heparin Market Size by Application
6.2.1 Middle East and Africa Crude Heparin Sales by Application (2016-2027)
6.2.2 Middle East and Africa Crude Heparin Revenue by Application (2016-2027)
6.3 Middle East and Africa Crude Heparin Market Size by Country
6.3.1 Middle East and Africa Crude Heparin Sales by Country (2016-2027)
6.3.2 Middle East and Africa Crude Heparin Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 UAE
11 Company Profiles
11.1 Bioiberica
11.1.1 Bioiberica Corporation Information
11.1.2 Bioiberica Overview
11.1.3 Bioiberica Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bioiberica Crude Heparin Product Description
11.1.5 Bioiberica Related Developments
11.2 Shenzhen Hepalink
11.2.1 Shenzhen Hepalink Corporation Information
11.2.2 Shenzhen Hepalink Overview
11.2.3 Shenzhen Hepalink Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Shenzhen Hepalink Crude Heparin Product Description
11.2.5 Shenzhen Hepalink Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi Crude Heparin Product Description
11.3.5 Sanofi Related Developments
11.4 Nanjing King-friend
11.4.1 Nanjing King-friend Corporation Information
11.4.2 Nanjing King-friend Overview
11.4.3 Nanjing King-friend Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Nanjing King-friend Crude Heparin Product Description
11.4.5 Nanjing King-friend Related Developments
11.5 Fengrun Biological Technology
11.5.1 Fengrun Biological Technology Corporation Information
11.5.2 Fengrun Biological Technology Overview
11.5.3 Fengrun Biological Technology Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Fengrun Biological Technology Crude Heparin Product Description
11.5.5 Fengrun Biological Technology Related Developments
11.6 Aspen Oss
11.6.1 Aspen Oss Corporation Information
11.6.2 Aspen Oss Overview
11.6.3 Aspen Oss Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Aspen Oss Crude Heparin Product Description
11.6.5 Aspen Oss Related Developments
11.7 Hebei Changshan Biochemical
11.7.1 Hebei Changshan Biochemical Corporation Information
11.7.2 Hebei Changshan Biochemical Overview
11.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Hebei Changshan Biochemical Crude Heparin Product Description
11.7.5 Hebei Changshan Biochemical Related Developments
11.8 Changzhou Qianhong
11.8.1 Changzhou Qianhong Corporation Information
11.8.2 Changzhou Qianhong Overview
11.8.3 Changzhou Qianhong Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Changzhou Qianhong Crude Heparin Product Description
11.8.5 Changzhou Qianhong Related Developments
11.9 Hepac (Darling Ingredients)
11.9.1 Hepac (Darling Ingredients) Corporation Information
11.9.2 Hepac (Darling Ingredients) Overview
11.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Hepac (Darling Ingredients) Crude Heparin Product Description
11.9.5 Hepac (Darling Ingredients) Related Developments
11.10 Huaian MDC Pharmaceutical
11.10.1 Huaian MDC Pharmaceutical Corporation Information
11.10.2 Huaian MDC Pharmaceutical Overview
11.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Description
11.10.5 Huaian MDC Pharmaceutical Related Developments
11.1 Bioiberica
11.1.1 Bioiberica Corporation Information
11.1.2 Bioiberica Overview
11.1.3 Bioiberica Crude Heparin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bioiberica Crude Heparin Product Description
11.1.5 Bioiberica Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Crude Heparin Value Chain Analysis
12.2 Crude Heparin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Crude Heparin Production Mode & Process
12.4 Crude Heparin Sales and Marketing
12.4.1 Crude Heparin Sales Channels
12.4.2 Crude Heparin Distributors
12.5 Crude Heparin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Crude Heparin Industry Trends
13.2 Crude Heparin Market Drivers
13.3 Crude Heparin Market Challenges
13.4 Crude Heparin Market Restraints
14 Key Findings in The Global Crude Heparin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Crude Heparin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin
Table 3. Major Manufacturers of Bovine Heparin and Others
Table 4. Global Crude Heparin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Crude Heparin Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Crude Heparin Sales by Region (2016-2021) & (MT)
Table 7. Global Crude Heparin Sales Market Share by Region (2016-2021)
Table 8. Global Crude Heparin Sales by Region (2016-2021) & (MT)
Table 9. Global Crude Heparin Sales Market Share by Region (2022-2027)
Table 10. Global Crude Heparin Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Crude Heparin Revenue Market Share by Region (2016-2021)
Table 12. Global Crude Heparin Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Crude Heparin Revenue Market Share by Region (2022-2027)
Table 14. Global Crude Heparin Sales by Manufacturers (2016-2021) & (MT)
Table 15. Global Crude Heparin Sales Share by Manufacturers (2016-2021)
Table 16. Global Crude Heparin Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Crude Heparin Revenue Share by Manufacturers (2016-2021)
Table 18. Crude Heparin Price by Manufacturers 2016-2021 (USD/Kg)
Table 19. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2020)
Table 21. Crude Heparin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Crude Heparin Product Offered
Table 23. Date of Manufacturers Enter into Crude Heparin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Crude Heparin Sales by Type (2016-2021) & (MT)
Table 26. Global Crude Heparin Sales by Type (2022-2027) & (MT)
Table 27. Global Crude Heparin Sales Share by Type (2016-2021)
Table 28. Global Crude Heparin Sales Share by Type (2022-2027)
Table 29. Global Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Crude Heparin Revenue Share by Type (2016-2021)
Table 32. Global Crude Heparin Revenue Share by Type (2022-2027)
Table 33. Crude Heparin Price by Type (2016-2021) & (USD/Kg)
Table 34. Global Crude Heparin Price Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Crude Heparin Sales by Application (2016-2021) & (MT)
Table 36. Global Crude Heparin Sales by Application (2022-2027) & (MT)
Table 37. Global Crude Heparin Sales Share by Application (2016-2021)
Table 38. Global Crude Heparin Sales Share by Application (2022-2027)
Table 39. Global Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Crude Heparin Revenue Share by Application (2016-2021)
Table 42. Global Crude Heparin Revenue Share by Application (2022-2027)
Table 43. Crude Heparin Price by Application (2016-2021) & (USD/Kg)
Table 44. Global Crude Heparin Price Forecast by Application (2022-2027) & (USD/Kg)
Table 45. North America Crude Heparin Sales by Type (2016-2021) & (MT)
Table 46. North America Crude Heparin Sales by Type (2022-2027) & (MT)
Table 47. North America Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Crude Heparin Sales by Application (2016-2021) & (MT)
Table 50. North America Crude Heparin Sales by Application (2022-2027) & (MT)
Table 51. North America Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Crude Heparin Sales by Country (2016-2021) & (MT)
Table 54. North America Crude Heparin Sales by Country (2022-2027) & (MT)
Table 55. North America Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Crude Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Crude Heparin Sales by Type (2016-2021) & (MT)
Table 58. Europe Crude Heparin Sales by Type (2022-2027) & (MT)
Table 59. Europe Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Crude Heparin Sales by Application (2016-2021) & (MT)
Table 62. Europe Crude Heparin Sales by Application (2022-2027) & (MT)
Table 63. Europe Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Crude Heparin Sales by Country (2016-2021) & (MT)
Table 66. Europe Crude Heparin Sales by Country (2022-2027) & (MT)
Table 67. Europe Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Crude Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Crude Heparin Sales by Type (2016-2021) & (MT)
Table 70. Asia Pacific Crude Heparin Sales by Type (2022-2027) & (MT)
Table 71. Asia Pacific Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Crude Heparin Sales by Application (2016-2021) & (MT)
Table 74. Asia Pacific Crude Heparin Sales by Application (2022-2027) & (MT)
Table 75. Asia Pacific Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Crude Heparin Sales by Region (2016-2021) & (MT)
Table 78. Asia Pacific Crude Heparin Sales by Region (2022-2027) & (MT)
Table 79. Asia Pacific Crude Heparin Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Crude Heparin Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Crude Heparin Sales by Type (2016-2021) & (MT)
Table 82. Latin America Crude Heparin Sales by Type (2022-2027) & (MT)
Table 83. Latin America Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Crude Heparin Sales by Application (2016-2021) & (MT)
Table 86. Latin America Crude Heparin Sales by Application (2022-2027) & (MT)
Table 87. Latin America Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Crude Heparin Sales by Country (2016-2021) & (MT)
Table 90. Latin America Crude Heparin Sales by Country (2022-2027) & (MT)
Table 91. Latin America Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Crude Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Crude Heparin Sales by Type (2016-2021) & (MT)
Table 94. Middle East and Africa Crude Heparin Sales by Type (2022-2027) & (MT)
Table 95. Middle East and Africa Crude Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Crude Heparin Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Crude Heparin Sales by Application (2016-2021) & (MT)
Table 98. Middle East and Africa Crude Heparin Sales by Application (2022-2027) & (MT)
Table 99. Middle East and Africa Crude Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Crude Heparin Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Crude Heparin Sales by Country (2016-2021) & (MT)
Table 102. Middle East and Africa Crude Heparin Sales by Country (2022-2027) & (MT)
Table 103. Middle East and Africa Crude Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Crude Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 105. Bioiberica Corporation Information
Table 106. Bioiberica Description and Major Businesses
Table 107. Bioiberica Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. Bioiberica Crude Heparin Product
Table 109. Bioiberica Recent Developments
Table 110. Shenzhen Hepalink Corporation Information
Table 111. Shenzhen Hepalink Description and Major Businesses
Table 112. Shenzhen Hepalink Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Shenzhen Hepalink Crude Heparin Product
Table 114. Shenzhen Hepalink Recent Developments
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Sanofi Crude Heparin Product
Table 119. Sanofi Recent Developments
Table 120. Nanjing King-friend Corporation Information
Table 121. Nanjing King-friend Description and Major Businesses
Table 122. Nanjing King-friend Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Nanjing King-friend Crude Heparin Product
Table 124. Nanjing King-friend Recent Developments
Table 125. Fengrun Biological Technology Corporation Information
Table 126. Fengrun Biological Technology Description and Major Businesses
Table 127. Fengrun Biological Technology Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Fengrun Biological Technology Crude Heparin Product
Table 129. Fengrun Biological Technology Recent Developments
Table 130. Aspen Oss Corporation Information
Table 131. Aspen Oss Description and Major Businesses
Table 132. Aspen Oss Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Aspen Oss Crude Heparin Product
Table 134. Aspen Oss Recent Developments
Table 135. Hebei Changshan Biochemical Corporation Information
Table 136. Hebei Changshan Biochemical Description and Major Businesses
Table 137. Hebei Changshan Biochemical Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Hebei Changshan Biochemical Crude Heparin Product
Table 139. Hebei Changshan Biochemical Recent Developments
Table 140. Changzhou Qianhong Corporation Information
Table 141. Changzhou Qianhong Description and Major Businesses
Table 142. Changzhou Qianhong Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Changzhou Qianhong Crude Heparin Product
Table 144. Changzhou Qianhong Recent Developments
Table 145. Hepac (Darling Ingredients) Corporation Information
Table 146. Hepac (Darling Ingredients) Description and Major Businesses
Table 147. Hepac (Darling Ingredients) Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Hepac (Darling Ingredients) Crude Heparin Product
Table 149. Hepac (Darling Ingredients) Recent Developments
Table 150. Huaian MDC Pharmaceutical Corporation Information
Table 151. Huaian MDC Pharmaceutical Description and Major Businesses
Table 152. Huaian MDC Pharmaceutical Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 153. Huaian MDC Pharmaceutical Crude Heparin Product
Table 154. Huaian MDC Pharmaceutical Recent Developments
Table 155. Yantai Dongcheng Biochemicals Corporation Information
Table 156. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 157. Yantai Dongcheng Biochemicals Crude Heparin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Yantai Dongcheng Biochemicals Crude Heparin Product
Table 159. Yantai Dongcheng Biochemicals Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Crude Heparin Distributors List
Table 163. Crude Heparin Customers List
Table 164. Crude Heparin Market Trends
Table 165. Crude Heparin Market Drivers
Table 166. Crude Heparin Market Challenges
Table 167. Crude Heparin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Market Share by Type in 2020 & 2027
Figure 3. Pig Intestine Mucosa Heparin Product Picture
Figure 4. Bovine Heparin and Others Product Picture
Figure 5. Global Crude Heparin Sales Market Share by Application in 2020 & 2027
Figure 6. Unfractionated Heparin (UFH)
Figure 7. Low-Molecular-Weight Heparin (LMWH)
Figure 8. Crude Heparin Report Years Considered
Figure 9. Global Crude Heparin Sales 2016-2027 (MT)
Figure 10. Global Crude Heparin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Crude Heparin Revenue 2016-2027 (US$ Million)
Figure 12. Global Crude Heparin Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Crude Heparin Sales Market Share by Region (2016-2021)
Figure 14. Global Crude Heparin Sales Market Share by Region (2022-2027)
Figure 15. North America Crude Heparin Sales YoY (2016-2027) & (MT)
Figure 16. North America Crude Heparin Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Crude Heparin Sales YoY (2016-2027) & (MT)
Figure 18. Europe Crude Heparin Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Crude Heparin Sales YoY (2016-2027) & (MT)
Figure 20. Asia-Pacific Crude Heparin Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Crude Heparin Sales YoY (2016-2027) & (MT)
Figure 22. Latin America Crude Heparin Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Crude Heparin Sales YoY (2016-2027) & (MT)
Figure 24. Middle East & Africa Crude Heparin Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Crude Heparin Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Crude Heparin Revenue in 2020
Figure 27. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Crude Heparin Sales Market Share by Type (2016-2027)
Figure 29. Global Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 30. Global Crude Heparin Sales Market Share by Application (2016-2027)
Figure 31. Global Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 32. North America Crude Heparin Sales Market Share by Type (2016-2027)
Figure 33. North America Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 34. North America Crude Heparin Sales Market Share by Application (2016-2027)
Figure 35. North America Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 36. North America Crude Heparin Sales Share by Country (2016-2027)
Figure 37. North America Crude Heparin Revenue Share by Country (2016-2027)
Figure 38. U.S. Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Crude Heparin Sales Market Share by Type (2016-2027)
Figure 41. Europe Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 42. Europe Crude Heparin Sales Market Share by Application (2016-2027)
Figure 43. Europe Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 44. Europe Crude Heparin Sales Share by Country (2016-2027)
Figure 45. Europe Crude Heparin Revenue Share by Country (2016-2027)
Figure 46. Germany Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 47. France Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Crude Heparin Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Crude Heparin Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Crude Heparin Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Crude Heparin Revenue Share by Region (2016-2027)
Figure 57. China Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 60. India Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 66. Philippines Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Crude Heparin Sales Market Share by Type (2016-2027)
Figure 68. Latin America Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Crude Heparin Sales Market Share by Application (2016-2027)
Figure 70. Latin America Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Crude Heparin Sales Share by Country (2016-2027)
Figure 72. Latin America Crude Heparin Revenue Share by Country (2016-2027)
Figure 73. Mexico Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Crude Heparin Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Crude Heparin Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Crude Heparin Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Crude Heparin Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Crude Heparin Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Crude Heparin Revenue Share by Country (2016-2027)
Figure 82. Turkey Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Crude Heparin Revenue (2016-2027) & (US$ Million)
Figure 85. Crude Heparin Value Chain
Figure 86. Crude Heparin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
  • 2021-2027 Global and Regional Hip and Knee Replacement Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Hip and Knee Replacement market was valued at 17253.29 Million USD in 2020 and will grow with a CAGR of 4.11% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East As......
  • 2021-2027 Global and Regional Stainless Steel Kirschner Wires Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global Stainless Steel Kirschner Wires market was valued at 23.11 Million USD in 2020 and will grow with a CAGR of 3.24% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, Eas......
  • 2021-2027 Global and Regional Biodegradable Stents Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global Biodegradable Stents market was valued at 724.75 Million USD in 2020 and will grow with a CAGR of 23.62% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Liposomal Doxorubicin Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 160
    The global Liposomal Doxorubicin market was valued at 1032.23 Million USD in 2020 and will grow with a CAGR of 7.32% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, ......
  • 2021-2027 Global and Regional Sample Collection Swabs Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 151
    The global Sample Collection Swabs market was valued at 22.62 Million USD in 2020 and will grow with a CAGR of 7.27% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, ......
  • 2021-2027 Global and Regional Hemostat Powder Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 156
    The global Hemostat Powder market was valued at 31.65 Million USD in 2020 and will grow with a CAGR of 5.34% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, ......
  • 2021-2027 Global and Regional Bionic Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 163
    The global Bionic Devices market was valued at 1198.57 Million USD in 2020 and will grow with a CAGR of 8.8% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, ......
  • 2021-2027 Global and Regional Medical Imaging Informatics Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 168
    The global Medical Imaging Informatics market was valued at 3582.76 Million USD in 2020 and will grow with a CAGR of 3.28% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East ......
  • 2021-2027 Global and Regional Bone Morphogenetic Protein (BMP) 2 Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 29-Sep-2021        Price: US 3500 Onwards        Pages: 161
    The global Bone Morphogenetic Protein (BMP) 2 market was valued at 38.03 Million USD in 2020 and will grow with a CAGR of 2.19% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs